- A cewar Stephane Bancel, yanayin COVID-19 a ƙarshe zai yi kama da na mura.
- An amince da rigakafin COVID-19 na Moderna a cikin ƙasashe kusan 100, yayin da kuma yana ɗaya daga cikin magunguna uku da aka yi amfani da su a kamfen ɗin rigakafi a Amurka.
- Za a sami jabs har ma ga jarirai ba da daɗewa ba har ma da allurai masu ƙarfafawa ga waɗanda za su buƙace su.
Babban Jami'in Kamfanin Moderna, Inc., wani kamfani na magunguna da fasahar kere-kere na Amurka da ke Cambridge, Massachusetts, Stephane Bancel, ya ba da shawarar cewa yanayin COVID-19 a ƙarshe zai zama kama da wanda ke da mura, kuma haɓaka samar da allurar rigakafi na iya gani. barkewar cutar coronavirus a ƙarshe tana zuwa ƙarshe a tsakiyar 2022.
Bancel ya ce a cikin wata hira da ya yi da cewa: "Idan kuka kalli fadada masana'antar da karfin samar da kayayyaki a cikin watanni shida da suka gabata, yakamata a sami isasshen allurai a tsakiyar shekara mai zuwa domin kowa da kowa a wannan Duniya ya sami allurar rigakafi."
A cewar babban jami'in kula da magunguna na Amurka, za a sami jabs har ma da jarirai nan ba da jimawa ba da kuma allurar rigakafi ga waɗanda za su buƙace su.
"Wadanda ba su yi allurar rigakafin ba za su yi wa kansu allurar rigakafi ta dabi'a saboda bambancin Delta yana da saurin yaduwa," in ji babban jami'in.
Lokacin da aka tambaye shi lokacin da bil adama za su iya fita daga cutar, wacce tuni ta ga mutane sama da miliyan 219 sun kamu da cutar kuma sama da miliyan 4.5 sun mutu, kuma sun koma rayuwarsu ta al'ada, Bancel ya amsa: "Daga yau, a cikin shekara guda, ina tsammanin."
ModeranaAn amince da allurar COVID-19 mai kashi biyu a wasu ƙasashe 100, yayin da kuma kasancewa ɗaya daga cikin magunguna uku da aka yi amfani da su a kamfen ɗin rigakafi a Amurka. Jab ɗin yana alfahari da ƙimar inganci na 93% watanni shida bayan gudanar da harbi na biyu, da kyar ya ragu daga kashi 94.5% da aka ruwaito yayin gwajinsa na uku na gwajin asibiti.
Koyaya, Bancel ya nace cewa waɗanda aka yiwa allurar "babu shakka" suna buƙatar mai ba da hutu a wani lokaci don samun kariya daga cutar. Ya ce yana sa ran matasa za su sami damar yin harbi sau ɗaya a kowace shekara uku da kuma tsofaffi - sau ɗaya a shekara.
ModeranaKara kuzari ya ƙunshi rabin kashi na sinadarin da ke aiki idan aka kwatanta da allurar asali, wanda ke ba wa kamfanin ƙarin damar haɓaka samarwa, in ji shi.
“Yawan allurar rigakafin shine babban abin iyakancewa. Tare da rabin kashi, za mu sami allurai biliyan uku a duk duniya don shekara mai zuwa maimakon biliyan biyu kawai, ” Moderana Shugaba yayi bayani.
Moderna yana cikin mutane shida masu yin allurar rigakafin Amnesty International da ake zargi da rura wutar rikicin 'yancin ɗan adam da ba a taɓa ganin irinsa ba' 'ta hanyar kin shiga cikin shirye -shiryen haɓaka samar da allurar rigakafin cutar a duniya tare da fifita haɗin gwiwa da ƙasashe masu arziki.
Dangane da rahoton Amnesty International, kamfanin na Amurka tare da irin su Pfizer-BioNTech, Johnson & Johnson, AstraZeneca da Novavax sun kasance masu laifin gaskiyar cewa daga cikin allurai biliyan 5.76 da ake gudanarwa a duk duniya, kashi 0.3% kawai sun tafi ƙasashe masu ƙarancin kuɗi. .
ABUBUWAN DA ZA KU GUDU DAGA WANNAN LABARI:
- , wani kamfanin harhada magunguna da fasahar kere-kere na Amurka da ke Cambridge, Massachusetts, Stephane Bancel, ya ba da shawarar cewa halin da ake ciki tare da COVID-19 zai zama kama da wanda ke da mura, kuma karuwar samar da alluran rigakafi na iya ganin cutar ta coronavirus a ƙarshe ta zo ƙarshe tsakiyar 2022.
- Mai haɓakawa na Moderna ya ƙunshi rabin kashi na kayan aiki idan aka kwatanta da allurar ta asali, wanda ke ba wa kamfanin ƙarin damar haɓaka haɓaka, in ji shi.
- Bancel ya ce a cikin wata hira da ya yi da cewa: "Idan kuka kalli fadada masana'antar da karfin samar da kayayyaki a cikin watanni shida da suka gabata, yakamata a sami isasshen allurai a tsakiyar shekara mai zuwa domin kowa da kowa a wannan Duniya ya sami allurar rigakafi."
